Applications of Neuroimaging to Disease-Modification Trials in Alzheimer’s Disease

Applications of Neuroimaging to Disease-Modification Trials in Alzheimer’s Disease

Critical to development of new therapies for Alzheimer’s disease (AD) is the ability to detect clinical or pathological change over time. Clinical outcome measures typically used in therapeutic trials have unfortunately proven to be relatively variable and somewhat insensitive to change in this slow...

Full description

Saved in:
Bibliographic Details
Main Authors: Adam S. Fleisher, Michael Donohue, Kewei Chen, James B. Brewer, Paul S. Aisen, the Alzheimer’s Disease Neuroimaging Initiative
Format: Article
Language:English
Published: Wiley 2009-01-01
Series:Behavioural Neurology
Online Access:http://dx.doi.org/10.3233/BEN-2009-0241
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items